                         SEQUENCE LISTING

<110>  COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES 
       ALTERNATIVES

       INSERM (Institut National de la Sant et de la Recherche Mdicale)
 
<120>  Method of selecting genetically modified hematopoietic stem cells

<130>  BEP170188 EP

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  1840
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic polynucleotide

<400>  1
ggctccggtg cccgtcagtg ggcagagcgc acatcgccca cagtccccga gaagttgggg       60

ggaggggtcg gcaattgaac cggtgcctag agaaggtggc gcggggtaaa ctgggaaagt      120

gatgtcgtgt actggctccg cctttttccc gagggtgggg gagaaccgta tataagtgca      180

gtagtcgccg tgaacgttct ttttcgcaac gggtttgccg ccagaacaca ggctagccac      240

catgacggag tataagccga ctgtcaggct ggccacaagg gacgatgtgc ccagggccgt      300

cagaactctg gcagcagctt tcgcagacta cccggcgacc agacatacgg tggaccctga      360

cagacatatt gagcgcgtga cggagttgca agaacttttc ttgacccgag tcggactcga      420

catcgggaag gtgtgggtgg cggatgatgg agcagccgtc gcggtatgga caacgcccga      480

atcagtcgag gctggagcgg tctttgcgga aatcggccct agaatggcgg aactttccgg      540

gagccggctg gcggcacagc agcagatgga gggactgttg gcacctcacc gcccgaaaga      600

gccggcctgg ttcctggcga cagtcggtgt atcacccgac caccagggga aaggtctggg      660

ttccgccgtg gtgttgcctg gagtggaggc agccgagaga gcaggggtcc cagcgttttt      720

ggaaaccagc gcgccacgga acctcccatt ctacgagcgg ctcggattca ccgtaacggc      780

cgacgtagaa gtaccggaag gacctcggac ttggtgcatg accagaaagc ccggtgcggg      840

gtcgatgccc actcttttgc gggtatacat tgatgggccg catggaatgg gaaagaccac      900

aacaacgcag ctccttgtcg cgctgggtag ccgggacgac attgtctatg tgcccgagcc      960

gatgacttac tggagggtat tgggtgcgag cgaaacgatt gccaacatct acactacaca     1020

gcaccgcttg gatcagggcg agatttcagc gggtgatgcc gcagtggtga tgacgtcggc     1080

gcagatcaca atgggaatgc cgtatgcggt gacggatgcg gtacttgcgc ctcacatcgg     1140

gggagaggcg ggctcctcgc atgcccctcc cccagcactc acgctcatct ttgatcgcca     1200

tccaatcgcc gctctccttt gctacccggc tgcccgatac ctgatgggtt cgatgacgcc     1260

ccaagctgta ttggcgtttg tcgcgttgat cccgcccacg ctgccaggga ccaatatcgt     1320

cttgggggca ttgcccgagg ataggcacat tgacagactg gccaaaaggc agaggcccgg     1380

agagcgattg gacttggcca tgctcgcggc cattagacgg gtgtatggat tgctcgcaaa     1440

tacggtgcgc tatctgcagt gtggtggatc atggcgcgag gactggggtc agctttcggg     1500

cactgcagta cccccgcaag gtgcagaacc ccagagcaac gcgggacccc gaccacacat     1560

cggagacacg ctgttcacat tgtttagagc ccccgaactt ctcgcgccta atggggacct     1620

ctacaacgta ttcgcatggg cgcttgatgt cttggcgaaa aggcttaggt cgatgcacgt     1680

gttcatcttg gattatgacc agtcgccggc aggatgcagg gatgctctgc tgcaactgac     1740

gtcggggatg gtgcagactc atgtgaccac ccccggatca attcctacta tctgtgatct     1800

ggcgcgcacc tttgcgcgag aaatggggga agccaattga                           1840


<210>  2
<211>  20
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  2
tgtgtgcccg tctgttgtgt                                                   20


<210>  3
<211>  19
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  3
cgagtcctgc gtcgagaga                                                    19


<210>  4
<211>  20
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  4
cagtggcgcc cgaacaggga                                                   20


<210>  5
<211>  25
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  5
tattagcacc atccatagga ggctt                                             25


<210>  6
<211>  22
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  6
gttagggaaa gtggagcgga ag                                                22


<210>  7
<211>  25
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  7
taacgcgtcc accaaggatg cgaat                                             25


